
De-risking nasal & pulmonary formulation development
To deliver therapeutics effectively to the nasal and pulmonary regions, developers must address the physiological barriers in these tissues. This webinar covers how formulation techniques and early in vitro toxicology work together to accelerate development and reduce risk.
DateCategory
Watch Time
37 minutes
To deliver therapeutics effectively to the nasal and pulmonary regions, developers must address the physiological barriers in these tissues.
This webinar covers how formulation techniques and early in vitro toxicology work together to accelerate development and reduce risk.
It explains the value of confirming structural and functional integrity early, highlights the benefits of spray‑drying for stability, particle control, and excipient incorporation, and outlines how toxicology and permeability testing provide evidence of safety and therapeutic potential.